Gene: ADCY1
Official Full Name: adenylate cyclase 1provided by HGNC
Gene Summary: This gene encodes a member of the of adenylate cyclase gene family that is primarily expressed in the brain. This protein is regulated by calcium/calmodulin concentration and may be involved in brain development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08813 | ADCY1 Knockout cell line (HEK293) | Human | ADCY1 | 1:3~1:6 | Negative | Online Inquiry |
KO08814 | ADCY1 Knockout cell line (A549) | Human | ADCY1 | 1:3~1:4 | Negative | Online Inquiry |
ADCY1 Gene Knockout Cell Lines are innovative biological research tools designed to study the functional implications of the adenylate cyclase 1 (ADCY1) gene. By employing precise genome editing techniques, these cell lines have been engineered to eliminate the expression of the ADCY1 gene, which plays a crucial role in converting ATP to cyclic AMP (cAMP), a secondary messenger involved in various signaling pathways that regulate physiological processes including metabolism, cell proliferation, and neuronal communication.
The primary function of these knockout cell lines is to facilitate comprehensive investigations into the downstream effects of ADCY1 deficiency, allowing researchers to examine alterations in cAMP levels and its subsequent impact on cellular responses. Utilizing quantitative assays, gene expression analysis, and signaling pathway evaluations in these cell lines, scientists can gain insights into the specific roles that ADCY1 plays in health and disease, including its potential involvement in conditions such as cardiovascular disorders and neurodegenerative diseases.
The scientific relevance of ADCY1 Gene Knockout Cell Lines extends to their application in drug discovery, therapeutic target validation, and elucidation of molecular mechanisms underpinning various pathophysiological states. They stand out in comparison to alternative cell models due to their specificity; traditional pharmacological inhibitors may not provide the same level of accuracy in evaluating gene function and compensatory mechanisms as knockout systems, which fully eliminate the gene of interest.
Researchers, clinicians, and pharmaceutical developers will find immense value in these cell lines, as they offer a reliable means to systematically pinpoint how the loss of ADCY1 affects cellular behavior. The precision provided by these knockout models enables more robust experimental designs, aligning with the increasing demand for accurate biological data in the context of personalized medicine.
Our company specializes in high-quality biological products, with a focus on advancing research through innovative tools like the ADCY1 Gene Knockout Cell Lines. We are committed to supporting the scientific community with reliable solutions that drive breakthrough discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.